pravastatin has been researched along with pyrazines in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blankley, CJ; Krause, BR; Newton, RS; Picard, JA; Roark, WH; Roth, BD; Sekerke, C; Shaw, MK; Sliskovic, DR; Stanfield, RL | 1 |
| Cummings, MH; Watts, GF | 1 |
| Fogari, R; Lusardi, P; Marasi, G; Preti, P; Vanasia, A; Zoppi, A | 1 |
| Hildebrandt, GC; Panu, LD; Shahan, JL | 1 |
1 trial(s) available for pravastatin and pyrazines
| Article | Year |
|---|---|
Comparative study of acipimox and pravastatin in patients with combined hyperlipidemia.
Topics: Adolescent; Adult; Cross-Over Studies; Double-Blind Method; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Middle Aged; Patient Compliance; Pravastatin; Pyrazines | 1997 |
3 other study(ies) available for pravastatin and pyrazines
| Article | Year |
|---|---|
Inhibitors of cholesterol biosynthesis. 6. trans-6-[2-(2-N-heteroaryl-3,5-disubstituted- pyrazol-4-yl)ethyl/ethenyl]tetrahydro-4-hydroxy-2H-pyran-2-ones.
Topics: Animals; Anticholesteremic Agents; Chemical Phenomena; Chemistry, Physical; Cholesterol; Dogs; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Molecular Structure; Pravastatin; Pyrazines; Pyrazoles; Pyridines | 1992 |
Drug treatment of hypercholesterolaemia in a patient with Gilbert's syndrome.
Topics: Administration, Oral; Bezafibrate; Bilirubin; Colestipol; Gilbert Disease; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipids; Liver; Liver Function Tests; Lovastatin; Male; Middle Aged; Pravastatin; Pyrazines; Simvastatin | 1994 |
Rhabdomyolysis in a multiple myeloma patient secondary to concurrent treatment with lenalidomide and pravastatin and to lenalidomide alone.
Topics: Amines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Boronic Acids; Bortezomib; Combined Modality Therapy; Creatine Kinase, MM Form; Cyclohexanecarboxylic Acids; Dexamethasone; Drug Synergism; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Immunologic Factors; Kidney Diseases; Lenalidomide; Melphalan; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Polyneuropathies; Pravastatin; Pyrazines; Rhabdomyolysis; Thalidomide | 2012 |